CDXFF: AI 评分 54/100 — AI 分析 (4月 2026)

Cloud DX Inc. operates a remote patient monitoring platform, offering end-to-end virtual healthcare solutions. The company's focus is on managing chronic illnesses and post-operative care through connected health kits and vital sign monitoring.

Key Facts: AI Score: 54/100 Sector: Healthcare

公司概况

概要：

Cloud DX Inc. provides a remote patient monitoring platform, enabling virtual healthcare for chronic illnesses and post-operative recovery. Their connected health kits and VITALITI monitor offer comprehensive data collection, serving hospitals, academic institutions, and health authorities in both Canada and the United States.

CDXFF是做什么的？

Cloud DX Inc. is a remote patient monitoring company that provides an end-to-end virtual healthcare platform. Founded with the vision of transforming healthcare delivery through technology, the company focuses on enabling remote monitoring of patients with chronic illnesses such as chronic obstructive pulmonary disease (COPD) and congestive heart failure. Their platform also supports patients recovering from surgery and those managing COVID-19 outside of traditional hospital settings. Cloud DX's core offering is the Cloud DX Connected Health platform, which includes connected health kits featuring devices like Bluetooth pulse oximeters and wireless weight scales. These kits can be expanded with optional third-party devices such as Bluetooth blood pressure monitors, digital thermometers, and glucose meters. The company also offers VITALITI, a vital sign monitor capable of measuring electrocardiograph (ECG), heart rate, oxygen saturation, respiration rate, core body temperature, blood pressure, movement, steps, and posture. Cloud DX serves a diverse range of clients, including academic institutions, large hospitals, and provincial health authorities in Canada, as well as physician practices and hospitals in the United States. The company's solutions aim to improve patient outcomes, reduce hospital readmissions, and enhance the efficiency of healthcare delivery. Headquartered in Kitchener, Canada, Cloud DX is committed to expanding its reach and impact in the rapidly evolving telehealth market.

CDXFF的投资论点是什么？

Cloud DX Inc. presents a notable market position within the expanding telehealth market. The company's comprehensive remote patient monitoring platform addresses the growing need for virtual healthcare solutions, particularly for chronic disease management and post-operative care. Key value drivers include increasing adoption of telehealth services, strategic partnerships with healthcare providers, and expansion into new geographic markets. The company's negative profit margin of -571.0% and negative gross margin of -247.9% indicate significant challenges in achieving profitability. Upcoming catalysts include potential contract wins with large hospital networks and expansion of the VITALITI product line. Investors should monitor the company's ability to improve its financial performance and secure sustainable revenue streams.

CDXFF在哪个行业运营？

Cloud DX Inc. operates within the rapidly growing telehealth and remote patient monitoring market. The industry is driven by factors such as an aging population, increasing prevalence of chronic diseases, and advancements in technology. The competitive landscape includes companies like ATBPF (Air T, Inc.), BNOEF (BioNxt Solutions Inc.), CNPOF (Care Net Population Health Management Inc.), CRBKF (Carebook Technologies Inc.), and DOCRF (CloudMD Software & Services Inc.), each offering various telehealth solutions. Cloud DX differentiates itself through its comprehensive platform and focus on chronic disease management.

Medical - Healthcare Information Services

Healthcare

CDXFF有哪些增长机遇？

Expansion into the US Market: Cloud DX has the opportunity to further penetrate the US market, leveraging the increasing adoption of telehealth solutions and the growing demand for remote patient monitoring services. The US telehealth market is projected to reach $55.5 billion by 2026, providing a significant growth runway for Cloud DX. Success in this market hinges on securing partnerships with US-based healthcare providers and demonstrating the value of its platform in improving patient outcomes and reducing healthcare costs.
Strategic Partnerships with Healthcare Providers: Forming strategic partnerships with hospitals, clinics, and other healthcare providers can significantly expand Cloud DX's reach and market penetration. These partnerships can provide access to a larger patient base and facilitate the integration of Cloud DX's platform into existing healthcare workflows. The company can leverage these partnerships to drive adoption of its connected health kits and VITALITI monitor, generating recurring revenue streams and establishing a strong foothold in the telehealth market.
Development of New Product Features and Services: Investing in the development of new product features and services can enhance the value proposition of Cloud DX's platform and attract new customers. This includes incorporating advanced analytics capabilities, integrating with other healthcare IT systems, and expanding the range of supported medical devices. By continuously innovating and adapting to the evolving needs of the market, Cloud DX can maintain a competitive edge and drive long-term growth.
Focus on Chronic Disease Management: Cloud DX can capitalize on the growing prevalence of chronic diseases by focusing its efforts on developing specialized solutions for managing conditions such as diabetes, heart disease, and respiratory illnesses. The chronic disease management market is estimated to reach $20 billion by 2028, presenting a significant opportunity for Cloud DX to establish itself as a leader in this space. This involves tailoring its platform to meet the specific needs of patients with chronic conditions and demonstrating the effectiveness of its solutions in improving patient outcomes and reducing healthcare costs.
Leveraging Government Incentives and Reimbursement Policies: Cloud DX can benefit from government incentives and reimbursement policies that support the adoption of telehealth and remote patient monitoring services. Many countries are implementing policies to encourage the use of telehealth, including providing reimbursement for remote patient monitoring services. By staying informed about these policies and actively engaging with government agencies, Cloud DX can position itself to take advantage of these opportunities and drive adoption of its platform.

Market Cap of $0.01B reflects its small size and growth potential within the telehealth market.
P/E ratio of -1.13 indicates the company is currently not profitable.
Profit Margin of -571.0% highlights significant challenges in achieving profitability.
Gross Margin of -247.9% suggests high costs associated with its services.
Beta of 0.44 indicates lower volatility compared to the overall market.

CDXFF提供哪些产品和服务？

Offers Cloud DX Connected Health, an end-to-end virtual healthcare platform.
Monitors patients with chronic illnesses like COPD and congestive heart failure remotely.
Supports patients recovering from surgery and COVID-19 patients outside hospitals.
Provides Cloud DX Connected Health Kits with Bluetooth pulse oximeters and wireless weight scales.
Offers VITALITI, a vital sign monitor for measuring ECG, heart rate, and other vital signs.
Serves academic institutions, hospitals, and health authorities in Canada and the US.

CDXFF如何赚钱？

Sells Cloud DX Connected Health Kits to healthcare providers and patients.
Generates revenue through subscription fees for access to the Cloud DX Connected Health platform.
Offers VITALITI vital sign monitors for continuous patient monitoring.
Partners with third-party suppliers for additional medical devices.

Academic institutions in Canada and the United States.
Large hospitals and healthcare systems.
Provincial health authorities in Canada.
Physician practices in the United States.

Proprietary Cloud DX Connected Health platform provides a comprehensive remote patient monitoring solution.
Established relationships with academic institutions, hospitals, and health authorities.
VITALITI vital sign monitor offers a unique and advanced monitoring capability.
Focus on chronic disease management provides a specialized market niche.

什么因素可能推动CDXFF股价上涨？

Upcoming: Potential contract wins with large hospital networks in the US.
Upcoming: Expansion of the VITALITI product line with new features and capabilities.
Ongoing: Increasing adoption of telehealth and remote patient monitoring services.
Ongoing: Strategic partnerships with healthcare providers to expand market reach.

CDXFF的主要风险是什么？

Potential: Intense competition in the telehealth market.
Potential: Changes in government regulations and reimbursement policies.
Ongoing: Negative profit margin and gross margin.
Ongoing: Limited market share compared to larger competitors.
Ongoing: Reliance on third-party suppliers for some medical devices.

CDXFF的核心优势是什么？

Comprehensive remote patient monitoring platform.
Connected Health Kits with various monitoring devices.
VITALITI vital sign monitor with advanced capabilities.
Established relationships with healthcare providers.

CDXFF的劣势是什么？

Negative profit margin and gross margin.
Limited market share compared to larger competitors.
Reliance on third-party suppliers for some medical devices.
OTC market listing may limit investor access.

CDXFF有哪些机遇？

Expansion into the US market.
Strategic partnerships with healthcare providers.
Development of new product features and services.
Focus on chronic disease management.

CDXFF面临哪些威胁？

Intense competition in the telehealth market.
Changes in government regulations and reimbursement policies.
Technological advancements by competitors.
Economic downturn affecting healthcare spending.

CDXFF的竞争对手是谁？

Air T, Inc. — Offers aviation services and overnight air cargo. — (ATBPF)
BioNxt Solutions Inc. — Focuses on pharmaceutical and nutraceutical products. — (BNOEF)
Care Net Population Health Management Inc. — Provides population health management solutions. — (CNPOF)
Carebook Technologies Inc. — Offers digital health and wellness platform. — (CRBKF)
CloudMD Software & Services Inc. — Provides virtual healthcare solutions and telehealth services. — (DOCRF)

Key Metrics

MoonshotScore: 54/100

Company Profile

CEO: Robert Manson Kaul
Headquarters: Kitchener, US
Founded: 2021

AI Insight

AI analysis pending for CDXFF

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does Cloud DX Inc. do?

Cloud DX Inc. operates as a remote patient monitoring company, offering the Cloud DX Connected Health platform, an end-to-end virtual healthcare solution. The company provides connected health kits and the VITALITI vital sign monitor to enable remote monitoring of patients with chronic illnesses, those recovering from surgery, and COVID-19 patients outside hospitals. Cloud DX serves academic institutions, hospitals, and health authorities in Canada and the United States, facilitating improved patient outcomes and efficient healthcare delivery through technology.

What do analysts say about CDXFF stock?

As of March 18, 2026, there is no readily available analyst consensus on CDXFF stock due to its OTC listing and limited coverage. Key valuation metrics indicate that the company is currently unprofitable, with a negative P/E ratio and negative profit and gross margins. Growth considerations include the company's potential to expand its market share in the telehealth industry and secure strategic partnerships. Investors should conduct their own due diligence and consider the risks associated with investing in OTC stocks.

What are the main risks for CDXFF?

The main risks for Cloud DX Inc. include intense competition in the telehealth market, potential changes in government regulations and reimbursement policies, and the company's current lack of profitability. Additionally, the company faces risks associated with its reliance on third-party suppliers for some medical devices and its limited market share compared to larger competitors. Investing in CDXFF also carries risks specific to OTC stocks, such as limited financial disclosure and regulatory oversight, higher price volatility, and liquidity constraints.